GLP-1 receptor agonists (GLP-1RAs) are currently used for treating type-2 diabetes and obesity because of their effects on appetite, food intake, and body weight loss
[137] Cost, coverage and supply [edit] In 2023, Ozempic, the semaglutide injection used for type 2 diabetes treatment, had list price of one-month supply of $936 in the US, $169 in Japan, $147 in Canada, $144 in Switzerland, $103 in Germany and the Netherlands, $96 in Sweden, $93 in the UK, and $87 in Australia
There are no current published reports, only theory from pharmacokietics
Signs Your GLP-1 Dose May Be Too High Heres the part almost nobody talks about: sometimes the problem isnt that your dose is too low
Some diabetics produce too much insulin, but their insulin is broken
Once-weekly options like semaglutide, dulaglutide, or exenatide extended-release offer convenience for patients who prefer less frequent injections